Cost-Effectiveness of Different Strategies for the Prevention of Venous Thromboembolism After Total Hip Replacement in China

被引：0
|
作者：
Xiaoyu Yan
Xiaohua Gu
Zhenxing Xu
Houweng Lin
Bin Wu
机构：
[1] Shanghai Jiao Tong University Affiliated Sixth People’s Hospital,Department of Orthopedics
[2] Shanghai Jiao Tong University Affiliated Sixth People’s Hospital,Department of Respiratory Medicine
[3] Shanghai Jiaotong University,Department of Cardiology, Renji Hospital, South Campus, School of Medicine
[4] Shanghai Jiaotong University,Medical Decision and Economic Group, Department of Pharmacy, Renji Hospital, School of Medicine
来源：
Advances in Therapy | 2017年 / 34卷
关键词：
Anticoagulation; Cardiology; Cost-effectiveness analysis; Venous thromboembolism;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：466 / 480
页数：14
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF DIFFERENT STRATEGIES FOR PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP REPLACEMENT IN CHINA
    Yan, X. Y.
    Gu, X. H.
    Zhou, L.
    Lin, H. W.
    Wu, B.
    VALUE IN HEALTH, 2016, 19 (07) : A866 - A866
  • [2] Cost-Effectiveness of Different Strategies for the Prevention of Venous Thromboembolism After Total Hip Replacement in China
    Yan, Xiaoyu
    Gu, Xiaohua
    Xu, Zhenxing
    Lin, Houweng
    Wu, Bin
    ADVANCES IN THERAPY, 2017, 34 (02) : 466 - 480
  • [3] Cost-effectiveness of venous thromboembolism prophylaxis after total hip replacement
    Caprini, JA
    Arcelus, JL
    Kudrna, JC
    Sehgal, LR
    Oyslender, M
    Maksimovic, D
    MacDougall, A
    PHLEBOLOGY, 2002, 17 (3-4) : 126 - 133
  • [4] COST-EFFECTIVENESS ANALYSIS OF RIVAROXABAN IN PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP REPLACEMENT IN SLOVAKIA
    Lukac, M.
    Bielik, J.
    Lees, M.
    Foltan, V
    Tomek, D.
    VALUE IN HEALTH, 2010, 13 (07) : A520 - A520
  • [5] COST-EFFECTIVENESS OF APIXABAN AND ENOXAPARIN FOR PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL KNEE REPLACEMENT IN CHINA
    Yan, X. Y.
    Gu, X. H.
    Bu, J.
    Lin, H. W.
    Wu, B.
    VALUE IN HEALTH, 2016, 19 (07) : A651 - A651
  • [6] COST-EFFECTIVENESS ANALYSIS OF RIVAROXABAN VERSUS DABIGATRAN AND ENOXAPARIN FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP REPLACEMENT
    Vorobyev, P.
    Krasnova, L.
    Borisenko, O.
    Lukyantseva, D.
    Bashlakova, E.
    VALUE IN HEALTH, 2011, 14 (03) : A40 - A40
  • [7] COST-EFFECTIVENESS OF RIVAROXABAN VERSUS ENOXAPARIN FOR PREVENTION OF VENOUS THROMBOEMBOLISM AFTER TOTAL HIP AND KNEE REPLACEMENT IN EUROPE
    Monreal, M.
    Ryttberg, L.
    Diamantopoulos, A.
    Lees, M.
    Negrini, C.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 50 - 51
  • [8] Cost-effectiveness of rivaroxaban for prevention of venous thromboembolism (VTE) after total hip or knee replacement (THR, TKR) in the USA
    Kwong, L.
    Duran, A.
    Diamantopoulos, A.
    Sengupta, N.
    Lees, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 787 - 787
  • [9] COST-EFFECTIVENESS OF DABIGATRAN ETEXILATE FOR THE PRIMARY PREVENTION OF VENOUS THROMBOEMBOLISM IN TOTAL HIP AND KNEE REPLACEMENT IN PORTUGAL
    Mateus, C.
    Wolowacz, S.
    Pereira, J. A.
    VALUE IN HEALTH, 2009, 12 (03) : A148 - A148
  • [10] Cost Effectiveness of Apixaban and Enoxaparin for the Prevention of Venous Thromboembolism After Total Knee Replacement in China
    Xiaoyu Yan
    Xiaohua Gu
    Lei Zhou
    Houweng Lin
    Bin Wu
    Clinical Drug Investigation, 2016, 36 : 1001 - 1010
12345